Skip to main content

Day: September 17, 2024

Bright Mountain Media (OTCQB: BMTM) Announces Appointment of AdTech Veteran Tom Triscari as Director and Compensation Committee Chair

Boca Raton, FL, Sept. 17, 2024 (GLOBE NEWSWIRE) — Bright Mountain Media, Inc. (OTCQB: BMTM) (“Bright Mountain” or the “Company”), a global marketing services platform with current investments in digital publishing, advertising technology, consumer insights, and creative and media services, announced via a FORM-31 on August 20, 2024, the appointment of Thomas Triscari to the Board of Directors and as Chair of the Compensation Committee. With a distinguished career in the AdTech and digital media industries, Thomas Triscari brings a wealth of experience to Bright Mountain Media. Currently a Senior Advisor at Landmark Ventures, Triscari is instrumental in developing a premier M&A advisory practice within the AdTech and Media sectors. He is also the Founder of the Forensic AdTech Collaborative Thinktank...

Continue reading

ibex Continues to Grow in the Philippines; Set to Open New Site in Davao

Award-Winning BPO Focuses on Employee Experience to Deliver World-Class Customer and Brand Interactionsibex to Open 2nd Site in Davao Cityibex expands to nine centers in the PhilippinesDAVAO CITY, Philippines, Sept. 17, 2024 (GLOBE NEWSWIRE) — ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and AI-powered customer engagement technology solutions, today announced that it will open its second customer experience (CX) service center in Davao City, located at Felcris Centrale, 40-D Quimpo Blvd., Talomo. This will bring ibex’s total number of sites in the Philippines to nine. “ibex is delighted to expand our operations in the Philippines and build on the amazing team and culture we have established here,” said ibex CEO Bob Dechant. “We continue to see strong demand globally from new and...

Continue reading

QHSLab Announces Major Research and Development Milestones for 2024: Doubling Assessment Completion and Advancing Digital Medicine Innovation

WEST PALM BEACH, FL, Sept. 17, 2024 (GLOBE NEWSWIRE) — QHSLab, Inc. (the “Company”) (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based healthcare solutions, today shared exciting updates on its Research & Development (R&D) activities, and patient outcomes for the year to date. The Company continues advancing healthcare technology by integrating AI-driven digital tools designed to improve clinical decision-making and patient care. Year-to-date as of September 2024, QHSLab’s platform has processed approximately 50,000 assessments, more than doubling the number of assessments completed during the same period last year. This represents a meteoric rise in assessment completions with the Company quickly bringing the total number of...

Continue reading

3D Systems Receives FDA Clearance for First-to-Market Multi-material, Monolithic Jetted Denture Solution

3D Systems Jetted Dentures3D Systems’ unique multi-material, single-piece dentures offer an unparalleled combination of distinctive break resistance and outstanding aesthetics for an enhanced patient experience.Unique multi-material, single-piece dentures offer unparalleled combination of distinctive break resistance and outstanding aesthetics for enhanced patient experience Solution being implemented by Glidewell, one of the world’s largest dental laboratories FDA clearance represents another important milestone in Company’s strategic initiative to expand its market-leading digital dentistry solution portfolio addressing alignment, protection, repair, replacement of teeth New denture product family significantly expands company’s addressable dental market, with denture demand estimated to exceed $2 billion by 2028ROCK...

Continue reading

Perma-Fix to Present at the Gabelli Funds’ 2nd Annual PFAS Symposium in New York City on September 26th

ATLANTA, Sept. 17, 2024 (GLOBE NEWSWIRE) — Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today announced that Dr. Louis Centofanti, Executive Vice President of Strategic Initiatives at Perma-Fix Environmental Services, will be presenting at the Gabelli Funds’ 2nd Annual PFAS Symposium, being held on Thursday, September 26th at the Harvard Club in New York City. Dr. Centofanti is scheduled to present at 1:30 PM ET. Management will also be participating in one-on-one meetings with qualified investors throughout the conference. To request a meeting, please contact James Carey at Gabelli & Company: jcarey@gabelli.com. The Gabelli Funds’ 2nd Annual PFAS Symposium will focus on issues surrounding PFAS uses, replacements, and remediation. It will feature presentations from leading companies in waste and disposal...

Continue reading

Tactical Resources Strengthens Position Amid Rare Earth Elements Market Disruptions

— Strategic U.S. Rare Earth Elements Project Advances Amid Global Supply Chain Shifts VANCOUVER, British Columbia, Sept. 17, 2024 (GLOBE NEWSWIRE) — Tactical Resources Corp. (TSXV: RARE) (OTC: USREF) (“Tactical Resources” or the “Company”), a mineral exploration and development company, provides a corporate update on its Peak Project in response to global rare earth elements (“REEs”) supply chain shifts triggered by China’s recent regulatory changes. Key HighlightsChina’s restrictions on REEs have disrupted global supply chains, emphasizing the need for diversified REE sources. The Peak Project is uniquely positioned as a U.S.-based REEs developer, helping reduce reliance on Chinese exports. Tactical Resources is advancing its work programs to become a significant REEs producer in the U.S.“China’s REE restrictions...

Continue reading

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

Completion of enrollment expected in Q4 with FDA submission for commercialization anticipated by the end of 2024 BRAINTREE, Mass., Sept. 17, 2024 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announced that it has successfully reached the midpoint of the ACCESS-PVI pivotal human clinical trial, enrolling and completing the follow up of 50% of the patients participating in the trial to evaluate the LIBERTY® Endovascular Robotic Surgical System. The Company expects to complete enrollment and follow up in the fourth quarter of 2024 and file its 510(k) submission with the U.S. Food and Drug Administration (FDA) by the end of 2024. ACCESS-PVI is a prospective, multi-center, single-arm, clinical trial designed to evaluate the performance and safety...

Continue reading

Crown Reiterates Third Quarter Guidance and Provides Film Division Update

LOS ANGELES, Sept. 17, 2024 (GLOBE NEWSWIRE) — Crown Electrokinetics Corp. (NASDAQ:CRKN) (“Crown” or the “Company”), a leading smart glass technology company and an expert in constructing fiber optic networks, today reiterated third quarter guidance and provided an update on progress within the Film Division. Q3 2024 GuidanceCrown remains on track to deliver third quarter revenues of $8 million, in line with the previously issued guidance. This will represent a sequential increase in revenue of approximately 70% as the Company continues to grow, diversify, and execute against its customer pipeline. Film Division Progress UpdateIn the first quarter, the development team overcame a significant hurdle in Crown’s mastering technology for the Dynamic Tint™ film. With the improved mastering process, the...

Continue reading

C-Bond Systems’ Patriot Glass Solutions Subsidiary Awarded Phase II of $163,000 Job from Large Movie Theater and Entertainment Company

Patriot Glass Solutions to install C-Bond Secure and Solar Film at Company’s Corporate Offices SAN ANTONIO, Sept. 17, 2024 (GLOBE NEWSWIRE) — C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a developer and marketer of glass strengthening solutions for enhanced safety, today announced that its Patriot Glass Solutions subsidiary has been awarded Phase II of a $163,000 job to install C-Bond Secure and solar film. The customer is a movie theater and entertainment center chain based in San Antonio, Texas. C-Bond’s glass strengthening protective solutions, sold through its Patriot Glass Solutions subsidiary, include C-Bond Secure, an application to deter forced entry, C-Bond BRS, a ballistic-resistant film system, and other film products such as graffiti film and reflective film. Patriot Glass Solutions’ patented technologies...

Continue reading

La Rosa Holdings Announces Intent to Acquire Real Estate Brokerage Firm with Over 950 Agents and More Than $19.0 Million in Revenue for 2023

Brokerage Firm Offers Proprietary Cloud-Based SaaS Platform for Real Estate Agents Celebration, FL, Sept. 17, 2024 (GLOBE NEWSWIRE) — La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a holding company for six agent-centric, technology-integrated, cloud-based, multi-service real estate segments, today announced that it has entered into a non-binding Letter of Intent to acquire a real estate brokerage firm with over 950 agents and offices in multiple states. The firm also offers a proprietary cloud-based Software-as-a-Service (SaaS) platform tailored for real estate agents and generated more than $19.0 million in revenue for 2023. Joe La Rosa, CEO of the Company, commented, “This potential strategic acquisition aligns with our vision of advancing technology-driven real estate solutions, expanding our market presence,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.